<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04825886</url>
  </required_header>
  <id_info>
    <org_study_id>CNUH-2017-319</org_study_id>
    <nct_id>NCT04825886</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease</brief_title>
  <official_title>Evaluation of Effectiveness and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease; A Multicenter, Prospective, Observational Registry Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonnam National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluation the efficacy and safety of Zotarolimus-Eluting Stent in patients&#xD;
      with long coronary artery disease of 25 mm or longer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objectives:&#xD;
&#xD;
      From this observational prospective study, the efficacy and safety of Zotarolimus-Eluting&#xD;
      Stent in patients with coronary artery disease longer than 25mm is planned to be&#xD;
      investigated.&#xD;
&#xD;
      Background:&#xD;
&#xD;
      Long coronary artery lesions are observed in 20% of all coronary interventions, and are&#xD;
      associated with poor clinical outcomes. Zotarolimus-Eluting Stents are a new type of stent&#xD;
      that combines the advantages of an Endeavour Resolute stent (drug eluting stent) and&#xD;
      Integrity stent (bare metal stent). In other words, BioLinx polymer is used which is an&#xD;
      advantage of Endeavour Resolute stent to secure clinical efficiency through stable drug&#xD;
      release while ensuring flexibility and excellent deliverability, which is the advantage of&#xD;
      Integrity stent. To date, there are only few studies to evaluate the efficacy and safety of&#xD;
      Zotarolimus-Eluting Stent in the treatment of coronary artery disease. Therefore, the&#xD;
      investigators planned to carry out a multicenter, prospective observational study to&#xD;
      evaluated the efficacy and safety of Zotarolimus-Eluting Stent in patients with long coronary&#xD;
      artery disease of 25 mm or longer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 28, 2017</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>Index admission to 12 months</time_frame>
    <description>Composite endpoint of clinically driven target lesion revascularization, myocardial infarction or cardiac death related to target vessel</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause death</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of all-cause death at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of cardiac death at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of myocardial infarction at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death or Myocardial infarction</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of all-cause death or myocardial infarction at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death or Myocardial infarction</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>umulative incidence rate of cardiac death or myocardial infarction at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of target vessel revascularization at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of target lesion revascularization at each visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>Index admission, 1 month, 6 months, 12 months</time_frame>
    <description>Cumulative incidence rate of stent thrombosis at each visit</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <condition>Coronary Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zotarolimus-Eluting Stent</intervention_name>
    <description>Percutaneous coronary intervention using zotarolimus-eluting stent</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Coronary artery disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 19 years old&#xD;
&#xD;
          -  Evidence of myocardial ischemia and coronary artery diameter stenosis≥ 50% and lesion&#xD;
             length ≥ 25mm&#xD;
&#xD;
          -  At least 2.5 mm diameter coronary vessel by visual estimation&#xD;
&#xD;
          -  Patients treated with Zotarolimus-eluting stent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous coronary stent implantation&#xD;
&#xD;
          -  Patients perticipated in other clinical trials of drugs or device&#xD;
&#xD;
          -  Target vessel saphenous vein graft&#xD;
&#xD;
          -  In-stent re-stenosis lesion&#xD;
&#xD;
          -  Contraindicated to anti-platelet agents or hypersensitivity&#xD;
&#xD;
          -  Past history of malignancy within 5 years&#xD;
&#xD;
          -  History of anaphylaxis to contrast agent&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
&#xD;
          -  Life expectancy &lt; 1-year&#xD;
&#xD;
          -  End stage renal disease on dialysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Min Chul Kim, MD</last_name>
    <phone>+82-62-220-6578</phone>
    <email>kmc3242@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gyeongsang National University Changwon Hospital</name>
      <address>
        <city>Changwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongwhi Park, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yu Jeong Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dankook University Hospital</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae-Soo Kang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tae-Soo Kang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Chungju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Woonggil Choi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Woonggil Choi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Daegu Catholic University Hospital</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Kean Ryu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jae-Kean Ryu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chang-Wook Nam, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chang-Wook Nam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyungpook National University Hospital</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hun Sik Park, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hun Sik Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ung Kim, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ung Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eulji Medical Center</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Jeong Choi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yu Jeong Choi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kongyang Univeristy Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jang Ho Bae, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jang Ho Bae, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Chul Kim, MD</last_name>
      <phone>+82-62-220-6578</phone>
      <email>kmc3242@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Youngkeun Ahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chosun University Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keun-Ho Park, MD</last_name>
    </contact>
    <investigator>
      <last_name>Keun-Ho Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wongkwang University Hospital</name>
      <address>
        <city>Iksan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok-Kyu Oh, MD</last_name>
    </contact>
    <investigator>
      <last_name>Seok-Kyu Oh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jeonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jei Kun Chae, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jei Kun Chae, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian Medical Center</name>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Young Rhew, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jay Young Rhew, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyungil Park, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kyungil Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Ho Heo, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jung Ho Heo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paik Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae-Hyun Yang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tae-Hyun Yang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kwang Soo Cha, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kwang Soo Cha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Carollo Hospital</name>
      <address>
        <city>Suncheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jang Hyun Cho, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jang Hyun Cho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pusan National University Yangsan Hospital</name>
      <address>
        <city>Yangsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kook Jin Chun, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kook Jin Chun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 27, 2021</study_first_submitted>
  <study_first_submitted_qc>March 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 27, 2021</last_update_submitted>
  <last_update_submitted_qc>March 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonnam National University Hospital</investigator_affiliation>
    <investigator_full_name>Min Chul Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Zotarolimus-Eluting Stent</keyword>
  <keyword>Long Coronary Artery Disease</keyword>
  <keyword>Target lesion failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

